Case Study: End-To-End Biologics Support

What does it take to move a molecule from concept to clinic? It’s often more steps – and more time – than biotechs think. Curia began working on an antibody discovery program in 2007. This timeline shows the many steps (and years) it took to move this molecule from concept to the clinic.

Curia is a global CDMO with 30+ years of experience guiding clients through the complexities of drug discovery, development, and manufacturing. Curia offers end-to-end support in the U.S. to get your biologic to the clinic faster, including: antibody discovery, small-scale protein production, cell line development, process and analytical method development, formulation development, GMP drug substance manufacturing, and GMP drug product manufacturing, all of which we've done to help this client advance their mAb to phase II clinical trials.